clinical trial · NCT00496834
LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)
Organon and Co·phase4·completed·n = 201
Hypertensionlosartan potassiumComparator: carvedilolComparator: losartan (+) hydrochlorothiazide (HCTZ)Comparator: carvedilol (+) hydrochlorothiazide
brief summary
The primary objective of this study is to evaluate efficacy, arterial stiffness measured by Pulse Wave Velocity (PWV) of Losartan potassium group compared to Carvedilol group after 24 weeks of treatment in patients with the essential hypertension.
started
Feb 1, 2008
primary completion
Sep 1, 2009
completion
Sep 1, 2009
last updated
May 22, 2024
official title
A Randomized, Open-label, Comparative, Non-inferiority, Multicenter Study to Compare Efficacy of Losartan Potassium Group and Carvedilol Group on Arterial Stiffness in Essential Hypertension Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol